Completed PHASE3 INTERVENTIONAL 2-arm NCT00890474

Moxibustion for Fetus in Breech Presentation

Sponsor: Loterie Romande

Interventions Moxibustion of the BL67 acupoint

Updated 4 times since 2017 Last updated: Apr 28, 2009 Started: Oct 31, 2004 Primary completion: Dec 31, 2008 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00890474, this PHASE3 trial focuses on Breech Presentation and remains completed. Sponsored by Loterie Romande, it has been updated 4 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Loterie Romande
Swiss National Science Foundation
University Hospital, Geneva

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland